Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.5650
-0.0488 (-7.95%)
At close: Nov 20, 2026, 4:00 PM EST
0.6000
+0.0350 (6.19%)
After-hours: Nov 20, 2026, 5:03 PM EST
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $21.36 million as of November 20, 2026. It is the 35,848th most valuable company in the world and the 5,043rd biggest in the United States. Its market cap has decreased by 64.66% in one year.
Market Cap
21.36M
Enterprise Value
-44.10M
1-Year Change
-64.66%
Global Rank
Country Rank
#5,043 United States
Category
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $21.36M, a decrease of -96.21%. That is a compound annual growth rate of -69.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 21.36M | -64.88% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 (IPO) | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 25.86M |
| Immutep | 25.58M |
| Lite Strategy | 24.99M |
| Polyrizon | 24.69M |
| GridAI Technologies | 24.43M |
| LeonaBio | 23.18M |
| ABVC BioPharma | 23.10M |
| TransCode Therapeutics | 22.50M |